A Ray Drogasil (RADL3) announced on Tuesday a new shareholders’ agreement, valid as of November, with a 10-year term and proposed changes to the board of directors.
The country’s largest pharmacy chain said in a statement that the new agreement, which comes into force on November 10, “reinforces the long-term commitment of the Galvão, Pires Oliveira Dias and Pipponzi families”, which together have 28.3% of the company.
The agreement also marks “closing the cycle of shareholders Guilherme Leal, Luiz Seabra and Pedro Passos as members of the RD control group, who remain as shareholders even after the expiration of the agreement currently in force”.
According to the company, the new agreement aims to improve governance and prepare the company for a business strategy that incorporates a series of elements of online retail and telemedicine, which were driven by social isolation measures in the country.
For several quarters, company executives have signaled Raia Drogasil’s efforts to invest in digitalization, omnichannel, marketplace and service offerings in pharmacies such as application of vaccines.
The company also stated that it will submit to the approval of investors proposed to expand, from three to five, the independent members of the board of directors, maintaining the representation of the current control group.
Among the independent members indicated are Sylvia Leão, who joined the retail chains Wal-Mart Brasil, GPA (PCAR3) e Carrefour Brazil (CRFB3); and Philipp Povel, president of online fashion retailer Dafiti.
The list maintains the independent director, Marco Bonomi, former director general of Itaú Unibanco.
Get the latest news delivered to your inbox
Follow us on social media networks